COVID-19 Update: We are currently shipping orders daily. However, due to transit disruptions in some geographies, deliveries may be delayed. To provide all customers with timely access to content, we are offering 50% off Science and Technology Print & eBook bundle options. Terms & conditions.
Inhaled Medicines - 1st Edition - ISBN: 9780128149744

Inhaled Medicines

1st Edition

Optimizing Development through Integration of In Silico, In Vitro and In Vivo Approaches

0.0 star rating Write a review
Editors: Stavros Kassinos Per Backman Joy Conway Anthony Hickey
Paperback ISBN: 9780128149744
Imprint: Academic Press
Published Date: 1st December 2020
Page Count: 550
Sales tax will be calculated at check-out Price includes VAT/GST

Institutional Subscription

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.


Inhaled Medicines: Optimizing Development through Integration of In Silico, In Vitro and In Vivo Approaches aims to show that technological ingredients for inhaled medicines are in place, setting the stage for a future of inhaled drug development based in large part on in silico studies. Opportunities and challenges are addressed by a number of experts who tackle drug delivery problems from different scientific angles. Chapters discuss regional deposition in vivo via respiratory imaging and experimental in vivo assessments of deposition that can be complimented by in vitro models in combination with in silico methods, amongst other timely topics.

Key Features

  • Gives a concise accounting of the-state-of-the art in key areas and technologies such as medical imaging, in silico methods, and device and drug formulation
  • Provides a clear description of the development, regulation and approval cycle of inhaled drugs
  • Considers healthcare needs driving the field, and where inhaled drugs could have the maximum impact


Pharmaceutical scientists and engineers working on inhalation products: including researchers in basic research and development, academic researchers, industrial researchers, doctoral researchers, and senior researchers; Regulators, policy makers, and funding agencies who require an overview of the potential of the technologies involved with inhaled medicines

Table of Contents

Section A: Introduction, medical need, current and future trends in drug and product development for inhalation drug delivery
1. Inhalation medicines: History, current and emerging medical needs
2. The optimal drug
3. Device and formulation

Section B: Understanding clinical performance
4. Understanding clinical performance of an inhaled medicine
5. Fate of the deposited dose: clinical methods to assess
6. Dose deposition pattern: In vitro measures
7. Dose Deposition pattern: In silico measures
8. Dissolution/drug release 
9. Local particulate clearance
10. Permeation and transport in airways 
11. Lung tissue interactions – approaching free concentrations in lung tissue target interaction

Section C: Bringing it all together – the role of in silico computational models
12. PK/ PBPK and mechanistic models:
13. In Silico Population Studies: Pulmonary imaging and simulations as an approach
14. The emerging state of the art: supporting the clinic
15. The emerging state of the art: supporting the product development, approval and regulation cycle


No. of pages:
© Academic Press 2021
1st December 2020
Academic Press
Paperback ISBN:

About the Editors

Stavros Kassinos

Per Backman

Per Backman is a Senior Inhalation Consultant at Emmace Consulting AB in Lund, Sweden

Joy Conway

Professor Joy Conway works in Respiratory Sciences at the Centre for Health and Life Sciences in Brunel University, London, UK.

Anthony Hickey

Ratings and Reviews